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Post-Golgi compartmentsgen-deﬁcient Chinese hamster ovary (CHO) mutant, ZPEG251, with a phenotype
of normal import of peroxisomal matrix and membrane proteins. In ZPEG251, plasmenylethanolamine
(PlsEtn) was severely reduced. Complementation analysis by expression of genes responsible for the
plasmalogen biogenesis suggested that alkyl-dihydroxyacetonephosphate synthase (ADAPS), catalyzing the
second step of plasmalogen biogenesis, was deﬁcient in ZPEG251. ADAPS mRNA was barely detectable as
veriﬁed by Northern blot and reverse transcription-PCR analyses. Defect of ADAPS expression was also
assessed by immunoblot. As a step toward delineating functional roles of PlsEtn, we investigated its
subcellular localization. PlsEtn was localized to post-Golgi compartments and enriched in detergent-resistant
membranes. Transport of PlsEtn to post-Golgi compartments was apparently affected by lowering cellular
ATP, but not by inhibitors of microtubule assembly and vesicular transport. Partitioning of cholesterol and
sphingomyelin, a typical feature of lipid rafts, was not impaired in plasmalogen-deﬁcient cells, including
peroxisome assembly-defective mutants, hence suggesting that PlsEtn was not essential for lipid-raft
architecture in CHO cells.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionPeroxisome functions in unique biochemical pathways including
various lipid metabolism such as synthesis of plasmalogens and
docosahexaenoic acid and β-oxidation of very long chain fatty acids
that are poorly oxidized in mitochondria. Plasmalogens are a major
subclass of ethanolamine and choline phospholipids in which a long
chain fatty alcohol is linked at sn-1 position through a vinyl ether
bond. The ﬁrst two reactions in plasmalogen biosynthesis are
catalyzed by dihydroxyacetonephosphate acyltransferase (DHAPAT)
and alkyl-dihydroxyacetonephosphate synthase (ADAPS) in peroxi-l-dihydroxyacetonephosphate
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l rights reserved.somes [1]. Physiological importance of plasmalogens is inferred from
the ﬁndings that plasmalogens are severely deﬁcient in specimens
from patients with various degenerative diseases and genetic
disorders such as Zellweger syndrome and rhizomelic chondrodys-
plasia punctata (RCDP) [2]. However, functional roles and subcellular
localization of plasmalogens remain elusive.
Several potential functions of plasmalogens have been proposed.
Plasmalogens likely play a role as an antioxidant, based on the
observation that plasmalogen-deﬁcient Chinese hamster ovary (CHO)
cells were less resistant to UV-induced oxidative stress [3,4].
Restoration of the plasmalogen content rescued such phenotypes of
the cell mutants [3,4]. Plasmalogens are also required for transport of
LDL-derived cholesterol from cell surface and/or endocytic compart-
ments to endoplasmic reticulum (ER) [5]. Plasmalogens are relatively
enriched in lipid-raft fractions [6,7]. Association of ﬂotillin-1 and F3/
contactin to lipid-raft microdomain is reduced in the brain of DHAPAT-
knockoutmice [8]. Subcellular distribution of plasmalogens is not fully
deﬁned, while several reports describe its presence in synaptic
vesicles [9,10] and secretory granules [11].
In CHO cells, 11% of the total phospholipids are plasmalogens,
primarily ethanolamine plasmalogen called plasmenylethanolamine
(PlsEtn) [12], excluding plasmenylcholine [13]. In the present study,
we isolated and characterized CHO cell mutant ZPEG251 defective in
plasmalogen synthesis, addressing transport of plasmalogens. We also
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deﬁcient cells.
2. Materials and methods
2.1. Biochemicals
Restriction enzymes and DNA-modifying enzymes were purchased from Nippon
Gene (Tokyo, Japan) and Takara (Tokyo, Japan). Fetal bovine serum and Ham's F-12
medium were from Invitrogen (Carlsbad, CA). We used rabbit antibodies to PTS1 [14],
thiolase [15], Pex14p [16], acyl-CoA oxidase (AOx) [15], 70-kDa peroxisomal integral
membrane protein [15], and malate dehydrogenase [17]. Antibodies against green
ﬂuorescent protein (GFP), cytochrome P450 reductase (P450R), Fyn, Gαq, H-Ras,
caveolin, and Na+/K+-ATPase α-subunit were purchased from Santa Cruz (Santa Cruz,
CA). Antibodies to Rab11 and ﬂotillin-2 were from BD Transduction Laboratories (San
Jose, CA). Antibody to transferrin receptor (TfR) was from Zymed (San Francisco, CA).
Anti-Syntaxin 6 antibody was from Stressgen (Ann Arbor, MI). PlsEtn puriﬁed from
bovine brain and chemically synthesized PlsEtn, 1-O-1′-(Z)-octadecenyl-2-oleoyl-sn-
glycero-3-phosphoethanolamine were purchased from Doosan Serdary Research
Laboratories (Kyungki-Do, Korea) and Avanti Polar Lipids (Birmingham, AL), respec-
tively. Other standard lipids, β-methyl cyclodextrin (β-MCD), and saponin were
purchased from Sigma (St. Louis, MO). Anti-mouse ADAPS antiserum was raised in
rabbits by injection of its C-terminal peptide, GC-KSVKEYVDPSNIFGNRNLL, coupled to
keyhole limpet hemocyanin [18].
2.2. ATP assay
Intracellular level of ATP was determined with an ELTIN ATP assay system, a
Bioluminescence Detection kit for ATP (Promega, Madison, WI), according to the
manufacturer's instruction.
2.3. Cell culture, selection of plasmalogen-deﬁcient CHO cell mutant, and DNA transfection
CHO cells were cultured in Ham's F-12medium supplementedwith 10% fetal bovine
serum under 5% CO2/95% air [15]. Mutagenesis was performed by exposure of TKaEG2
cells [19] to 3-chloro-7-methoxy-9-(3-[chloroethyl]-amino propylamino)-acridine
dihydrochloride (ICR191; Sigma) at 0.4 μg/ml for 8 h [20]. Cell colonies resistant to the
treatment with 9-(1′-pyrene)nonanol/ultraviolet (P9OH/UV) but showing morphologi-
cally normal peroxisome assembly were isolated and analyzed for their plasmalogen
levels as described below. For supplementation of PlsEtn, cells were cultured for 48 h in
the presence of 10 μM sn-1-hexadecylglycerol (HG) [3]. Bovine brain PlsEtn and 1-O-1′-
(Z)-octadecenyl-2-oleoyl-sn-glycero-3-phosphoethanolamine were separately dried up
in tubes, resuspended in F-12 medium by sonication, and likewise added every 24 h to
the culture medium at 46 μM. DNA transfection was performed as described [21].
2.4. Lipid extraction
Cells were metabolically labeled with 14C-ethanolamine (Amersham Biosciences,
Tokyo, Japan) [1] for 5 h and harvested after washing with PBS. Suspended cells were
treated with 5% of trichloroacetic acid (TCA) for 30 min at room temperature and
precipitated. Lipids were extracted according to Bligh and Dyer [22]. 14C-labeled lipids
were resolved on thin-layer chromatography (TLC) plates (silica gel 60, Merck KgaA,
Darmstadt, Germany) using chloroform/methanol/acetic acid (65/25/10) and quantiﬁed
by phosphorimaging using FLA-5000 Imaging Analyzer (Fuji Film. Tokyo, Japan). For
cholesterol, extracted lipids were resolved in hexane/diethyl ether/acetic acid (80/20/
1.5) and detected by iodine vapor [23]. For lipid analysis of subcellular fractions, lipids
were extracted, re-suspended in PBS containing 1% defatted BSA, and re-extracted after
TCA treatment.
2.5. Subcellular fractionation
CHO-K1 cells grown to a conﬂuent stage in a 10-cm culture dish were metabolically
labeled with 14C-ethanolamine for 18 h. Cells were homogenized with a homogenizing
buffer (HB, 0.25 M sucrose/1 mM EDTA in 10 mM HEPES-KOH, pH 7.4) by passing
through a 23-G needle 20 times. Post-nuclear supernatant (PNS) fraction was adjusted
to 20 or 12.5% (w/v) iodixanol with OptiPrep (60% iodixanol) [24] (Invitrogen) and
centrifuged for 3 h at 186,000×g or 348,000×g, respectively, in an NVTi65 rotor
(Beckman Instruments, Fullerton, CA). Ten 1 ml-fractions were collected from the
bottom of tubes.
2.6. Treatment of cells with cholesterol-affecting agents
CHO-K1 cells were washed three times with phosphate-buffered saline and treated
with either 10 mM β-MCD for 1 h at 37°C in F12 minus FCS or 0.4% saponin in
phosphate-buffered saline for 1 h at 4°C.
2.7. Flotation
Cells were metabolically labeled with 14C-ethanoamine or 14C-acetate (Amersham)
[25,26] for 18 h, harvested and resuspended in 300 μl of HB. Two hundred seventymicroliters of cell homogenate was treated with 30 μl of 10% Triton X-100 on ice for 30
min and was adjusted to 40% iodixanol with 600 μl of OptiPrep. The sample (700 μl) in
TLS55 centrifuge tubes (Beckman) was overlaid with 1.2 ml of 30% iodixanol/HB and 0.1
ml of 10 mM HEPES-KOH, pH 7.4, and centrifuged at 55,000 rpm (259,000×g) for 2 h.
Two 1-ml fractions were collected from the top. Detergent-free rafts were prepared as
follows. Conﬂuent cells in one 10-cm dish were scraped into HB/Tris buffer (0.25 M
sucrose and 20mM Tris–HCl, pH 7.8) containing 1mMCaCl2 and 1mMMgCl2 [27]. Cells
were pelleted and homogenized with HB/Tris buffer as above. PNS faction was adjusted
to 30% iodixanol with Optiprep, overlaid with 0.4 ml of 20% iodixanol/HB/Tris, 0.9 ml of
5% iodixanol/HB/Tris, and 0.1 ml of HB/Tris, and centrifuged at 55,000 rpm for 1 h in a
TLS55 rotor. Five 400-μl fractions were collected from the top.
2.8. Cloning of ADAPS from CHO cells
Chinese hamster (Cl) ADAPS was cloned as follows. Total RNA was prepared from
wild-type CHO-K1 cells using an RNeasy kit (Qiagen, Hilden, Germany) and ﬁrst strand
cDNA was obtained by reverse transcription (RT). A 398-bp fragment was ampliﬁed
using primers designed from human ADAPS-cDNA sequence [28], a sense ADAPSFw1
(5′-TTATGAAATGGAATGGATGGG-3′) and an antisense ADAPSRv1 (5′-CACAATCTTAAC-
TACATCATCATG-3′). Based on the sequence of PCR fragment, we prepared another
speciﬁc primer set for ClADAPS, ClADAPSFwA (5′-CTATAATGATTCCAAGTTCTTCTTC-3′)
and ClADAPSRvA (5′-AACAACTATATCAGGAATCCGTTCC-3′). Approximately 2.0×105
independent colonies of cDNA library from wild-type CHO-K1 cells in pSPORT [14]
were divided into small pools. Each pool was veriﬁed for ClADAPS by PCR with a set of
primers, ClADAPSFwA and ClADAPSRvA. The positive pool was further divided into
smaller pools until a single clone of ClADAPS was isolated. Nucleotide sequencing of
both strands was done by a Dye-terminator DNA sequence kit (Applied Biosystems,
Foster City, CA).
2.9. Mutation and mRNA-level analysis
ADAPS in ZPEG251 was assessed as follows. Total RNA was obtained from ZPEG251
as described above. RT-PCR was done with a pair of ClADAPS5′non (5′-
CCACGCGTCCGGGCGGAAGCC-3′) and ClADAPSRvA, and ClADAPSFwA and ClADAPS3′
non (5′-CTGGTATAACCATAGCTGATGACT-3′), to cover a full-length ADAPS open reading
frame. The nucleotide sequence of the PCR products cloned in T-easy vector (Promega)
was determined as above.
For Northern blotting, the blot of total RNA from wild-type CHO-K1 and ZPEG251
was hybridized with α-32P-dCTP-labeled PCR products that had been ampliﬁed with a
pair of ClADAPSFwB and ClADAPSRvB (nucleotide residues 931–1560) of ClADAPS. RT-
PCR was performed with primers for ADAPS, ClADAP1748Fw: AACCGAGGCAGCTGCTA-
GAGATG and ClADAP1904Rv: CTGGGGTCCACATATTCCTTGACAG covering 157-bp
sequence, and those for 227-bp long actin DNA as a control, sense primer:
AAGATGACCCAGATCATG and antisense primer: AGGATCTTCATGAGGTAG.
2.10. Construction of ADAPS-HA2
ClADAPS-HA2 was ampliﬁed by PCR using primers Hind/ClADAPS5′Fw (5′-
CCCAAGCTTGCCACCATGGCGGAGGCGGCGGGCGA-3′) and ClADAPS-HA2/XbaRV (5′-
GCTCTAGATTAATAATCGGGCACATCGTAGGGGTACGCATAATCGGGCACATCGTAGGGG-
TACGCCAAAAGGTTTCTGTTTCCAAAGATG-3′). PCR product was digested with HindIII
and XbaI and cloned into the HindIII–XbaI site of pcDNA3.1Zeo (Invitrogen).
3. Results
3.1. Isolation and characterization of plasmalogen-deﬁcient cell mutant
We mutagenized parent TKaEG2 cells [19], the wild-type CHO-K1
stably expressing both rat Pex2p and enhanced green ﬂuorescent
protein N-terminally tagged with peroxisome targeting signal type 2
(PTS2-EGFP), and searched for P9OH/UV-resistant cell colonies
showing morphologically normal PTS2-EGFP import to peroxisomes.
Of several P9OH/UV-resistant colonies, one cell clone named ZPEG251
showed peroxisomal localization of PTS2-EGFP and PTS1 proteins as
well as peroxisomal membrane protein, Pex14p (Fig. 1A). Moreover,
the conversion of 75-kDa AOx-A component to 53-kDa B- and 22-kDa
C-components and the processing of 44-kDa precursor to 41-kDa
mature form of 3-ketoacyl-CoA thiolase (thiolase) were evident in
both CHO-K1 [15] and ZPEG251 cells, while only A-component of AOx
and the thiolase precursor were detected in well-characterized
peroxisome-defective CHO mutant, pex2 Z65, as reported [15] (Fig.
1B). Such cellular phenotypes suggested that plasmalogen biosynth-
esis, but not the assembly of peroxisomes, was impaired in ZPEG251,
similar to plasmalogen-deﬁcient cell mutant NZel-1 isolated by Nagan
et al. [1].
Fig. 1. Biogenesis of peroxisomal proteins in ZPEG251. (A) Intracellular localization of
peroxisomal membrane protein and matrix proteins. ZPEG251 cells were stained with
antibodies to Pex14p (a) and PTS1 (b) or were directly observed for EGFP ﬂuorescence
derived from PTS2-EGFP. Scale bar, 10 μm. (B) Processing of AOx and thiolase was
accessed by immunoblotting of cell-lysates from pex2 Z65, CHO-K1, and ZPEG251 cells
with antibodies to AOx (upper panel), thiolase (middle panel), and actin (lower panel).
Full length of AOx-A is converted to B- and C-chains in peroxisomes [15]. P and M,
precursor and mature forms of thiolase, respectively.
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Next, we analyzed plasmalogen level in ZPEG251. We ﬁrst
attempted to establish a simple method to detect PlsEtn on one-
dimensional TLC. The alkenyl ether linkage at the sn-1 position of
plasmalogen is acid-labile [29]. We therefore used TCA to hydrolyze
the alkenyl ether bond. To verify this method, we treated PE and
PlsEtn with TCA and analyzed them by TLC. PE and PlsEtn were
detected at the same position before the TCA-treatment. In contrast,
one distinct band with a slower mobility was discernible only after
the incubation of PlsEtn, not PE, with TCA, strongly suggesting that
PlsEtn was converted to 2-acylglycerophosphoethanolamine (lyso-
PE) (Fig. 2A). To assess whether PlsEtn was converted to lyso-PE,
wild-type CHO-K1 and pex2 Z65 impaired in plasmalogen biogen-
esis [15] were metabolically labeled with 14C-ethanolamine. Upon
the TCA-treatment, a slower migrating band corresponding to lyso-
PE was evident in the case of CHO-K1, while an increased level of
the diacylated PE and a barely detectable level of lyso-PE were
detected in pex2 Z65 (Figs. 2B and C). These results indicated that
PlsEtn was indeed converted lyso-PE by the TCA-treatment. More-
over, lyso-PE was readily separated from other cellular lipids by
one-dimensional TLC (Fig. 2C), allowing one-step analysis from the
cultured cells. In ZPEG251 cells, PlsEtn was reduced to less than 10%
level of CHO-K1 (Fig. 3C, lanes 1 and 2), hence strongly indicating
that ZPEG251 was defective in plasmalogen synthesis.
To conﬁrm the impaired plasmalogen biosynthesis in ZPEG251,
we cultured ZPEG251 cells in the presence of HG that is sufﬁcient to
completely recover plasmalogen levels by bypassing the ﬁrst three
steps of biosynthetic pathway of plasmalogen [1,3]. Plasmalogen
content in ZPEG251 was increased to the level in CHO-K1 by
supplementing with HG, thereby indicating that ZPEG251 was
indeed defective at least in one of the ﬁrst three steps of
plasmalogen biosynthesis pathway. Supplementation of HG to
CHO-K1 gave rise to a little increase in plasmalogens (data not
shown). To verify which step is impaired in ZPEG251 cells, cDNAs
each encoding EGFP-tagged human DHAPAT and ADAPS (Koga, K. et
al., unpublished results) were transfected. Ectopic expression of
ADAPS-EGFP, but not EGFP-DHAPAT, enhanced the plasmalogen
level of ZPEG251 as that with HG (Fig. 3B), strongly suggesting that
ADAPS was affected. To determine the dysfunction of ADAPS in
ZPEG251 cells, we ﬁrst isolated ADAPS cDNA from CHO-K1 cDNA
library. This cDNA, termed Chinese hamster (Cl) ADAPS, was 3791
bp in length with an open reading frame encoding a protein
consisting of 644 amino acids. ClADAPS was the same in amino acid
residue number as rat ADAPS with 97% identity (SwissProt
accession number G9EQR2) but was shorter by one amino acid
and 14 residues than mouse ADAPS (SwissProt accession number
G8COI1) with 96% identity and guinea pig and human ADAPS with
93% identity [28,30], respectively (Fig. 3F). We then isolated a cell
line ZPEG251/ClADAPS-HA2, ZPEG251 stably expressing ClADAPS-
HA2 (Fig. 3C, lower panel, lane 3), where ClADAPS-HA2 was
imported to peroxisomes and processed to its mature form (data
not shown). In ZPEG251/ClADAPS-HA2 cells, the PlsEtn deﬁciency in
ZPEG251 was restored to a normal level (Fig. 3C, upper panel, lanes
2 and 3).
ADAPS was barely detected in ZPEG251 as veriﬁed by Western
blotting (Fig. 3C, lower panel; Fig. 3D, upper panel). In contrast, a
larger precursor of ADAPS was detected in pex2 Z65 and mature
ADAPS was evident in CHO-K1 and parent TKaEG2 used for
mutant ZPEG251 isolation, as expected (Fig. 3C, lower panel; Fig.
3D, upper panel). In Northern blot, ADAPS mRNA was detected as
a single band in total RNA from CHO-K1 cells (Fig. 3E, upper
panel). In contrast, in ZPEG251 a signiﬁcantly reduced level of
ADAPS mRNA was evident, with no detectable spliced variants.
These results were conﬁrmed by RT-PCR analysis (Fig. 3E, lower
panel). No mutation was found in the open reading frame ofZPEG251-derived ADAPS cDNA (data not shown), implying the
alteration at a transcriptional level or rapid degradation of ADAPS
mRNA in ZPEG251. Taken together, we concluded that the
plasmalogen deﬁciency in ZPEG251 was caused by a signiﬁcant
reduction in the ADAPS expression level.
3.3. Intracellular distribution of PlsEtn
To understand the physiological consequence of plasmalogens,
their intracellular localization needs to be elucidated. However,
mainly owing to less available methodologies, the subcellular
localization of PlsEtn has been little studied. Here, we investigated
the intracellular localization of PlsEtn by a combination of one-step
PlsEtn detectionmethod (see Fig. 2) and subcellular fractionation. PNS
fraction prepared from CHO-K1 cells that had been metabolically
labeled with 14C-ethanolamine was subjected to ultracentrifugation
on a self-generated 20% iodixanol gradient. Ten equal-volume
fractions were collected from the bottom of the gradient and analyzed
for organelle distribution by Western blot using antibodies each
speciﬁc for Na+/K+-ATPase (a marker for plasmamembranes (PM)) [7],
P450R (amarker for ER) [31], syntaxin 6 (amarker for Golgi apparatus)
[32], Rab11 (a marker for recycling endosomes) [33], malate
dehydrogenase (a marker for mitochondria) [17], and 70-kDa
peroxisomal integral membrane protein (a marker for peroxisomes)
(Fig. 4A). Peroxisomes were separated into the bottom fraction and
were free from the other organelles. Lipid analysis showed that PlsEtn
was mostly recovered in the lower-density fractions and under the
detectable level in the higher-density, peroxisomal fractions (Fig. 4A).
In the peroxisomal fraction, PC was detectable, while other lipids such
as PE were under the detectable level. It is noteworthy that PC was a
major lipid and PE and cholesterol were present in an amount less
than PC in peroxisome membranes [34,35]. Upon fractionation of PNS
on a 12.5% iodixanol gradient, sphingomyelin (SM) was well separated
from the ER marker P450R and co-sedimented with Na+/K+-ATPase
Fig. 3. Levels of PlsEtn and ADAPS in ZPEG251 cells. (A) Levels of PlsEtn in ZPEG251. Note
that a barely detectable level of PlsEtn in ZPEG251 was restored to the level in CHO-K1
by supplementing with HG. (B) Restoration of PlsEtn level in ZPEG251 by expressing
EGFP-tagged ADAPS, but not EGFP-DHAPAT. (C) Restored PlsEtn level in ZPEG251 cells
stably expressing ClADAPS-HA2. Expression levels of ADAPS were accessed by
immunoblotting with anti-ADAPS antibody. Solid and open arrowheads indicate
endogenous ADAPS in CHO-K1 and ADAPS-HA2, respectively. (D) Western blot analysis
of ADAPS. ADAPS was veriﬁed by immunoblotting of cell-lysates from pex2 Z65, CHO-
K1, parent TKaEG2 used for mutant isolation, and ZPEG251 with antibodies to ADAPS
(upper panel). Actin was used as an internal control (lower panel). P and M, precursor
and mature forms of ADAPS, respectively. (E) Expression level of ADAPS mRNA. (Upper
panel) Northern blot. RNA from CHO-K1 (lane 1) and ZPEG251 (lane 2) was separated,
transferred to a Zeta-probe GT membrane, and hybridized with 32P-labeled 630-bp
partial fragment of ADAPS cDNA. TubulinmRNAwas assessed as a control. (Lower panel)
RT-PCR was performedwith primers speciﬁc for ADAPS and actin as a control. (F) Amino
acid sequence alignment at the N-terminal region of Chinese hamster (Cl) and human
(Hs) ADAPS. Identical amino acids between two species are shaded. PTS2 sequence is
overlined. Note that ClADAPS was shorter by 14 amino acids than HsADAPS (see text).
The GenBank™ database accession number for Chinese hamster ADAPS is AB363974.
Fig. 2. Detection of plasmalogens. (A) A plasmalogen, plasmenylethanolamine (PlsEtn),
was detected as 2-acylglycerophosphoethanolamine (lyso-PE). PE and PlsEtn were
treated with (+) or without (−) TCA and were analyzed by TLC. (B) CHO-K1 and pex2 Z65
cells were metabolically labeled with 14C-ethanolamine for 5 h. Total lipids were
extracted from TCA-treated cell-lysates. Note that lyso-PE was not detected from pex2
Z65 cells. (C) Total lipids of CHO-K1 and pex2 Z65 cells were detected with iodine vapor.
PC, phosphatidylcholine; PI, phosphatidylinositol; PS, phosphatidylserine. Note that
lyso-PE was separated from other cellular lipids.
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the gradient with the highest peak at the bottom fraction where
several different organelle membranes including ERwere sedimented.
Quantiﬁcation of the lyso-PE intensity indicated that PlsEtn was
sedimented with Na+/K+-ATPase and Rab11 and to the bottom fraction
(Fig. 4C). Taken these results together, PlsEtn was more likely
distributed to post-Golgi compartments, such as plasma membranes
and endosomes, and ER.
3.4. Transport pathway of plasmalogens
The ﬁrst two steps of plasmalogen synthesis proceed in
peroxisomes and the remaining reactions are catalyzed by ER
enzymes [36]. PlsEtn is likely transported from its synthesis site,
ER, to several late compartments in the exocytic pathway (see Fig. 4).
However, the trafﬁcking of PlsEtn after its biosynthesis is poorly
deﬁned at present. PlsEtn is enriched in lipid rafts, small assemblies
enriched in cholesterol and sphingolipids, that are assembled in the
Golgi complex in mammalian cells [37] and most abundant in late
compartments of exocytic route including plasma membranes and
recycling endosomes [38,39]. Thus, we attempted to assess the
translocation of PlsEtn to the post-Golgi compartments by monitor-
ing the partition of PlsEtn into detergent-resistant membranes
(DRMs). CHO-K1 cells were metabolically labeled with 14C-ethano-
lamine for 4.5 h and separated into DRM and Triton X-100 soluble
fractions by ﬂoatation on a 40% iodixanol gradient. In CHO-K1 cells,
ﬂotillin-2, a raft marker protein [40], was mostly recovered in DRMs,
while TfR, a non-raft protein, was completely solubilized by Triton X-
100 (Fig. 5B, lanes 1 and 2). Lipid analysis showed that SM was
predominantly separated into DRMs, while 30% of total PlsEtn was in
DRMs (Table 1). With respect to the ratio of PlsEtn to glyceropho-spholipids, PlsEtn was 1.7-fold enriched in DRMs as compared to
that of the total cells (Table 1).
Moreover, upon the treatment of CHO-K1 cells with β-MCD or a
cholesterol-sequestering detergent, saponin, disrupting lipid rafts
and consequently reducing the recovery of typical raft components
in DRMs [41], total cellular cholesterol was removed by β-MCD,
Fig. 4. Intracellular distribution of PlsEtn. PNS fraction from CHO-K1 cells that had been
metabolically labeled with 14C-ethanolamine was fractionated on 20% (A) or 12.5% (B)
iodixanol gradient as described in Materials and methods. An equal volume of each
fraction was analyzed by SDS-PAGE and immunoblot with antibodies to various
organelle-marker proteins. PMP70, 70-kDa peroxisomal integral membrane protein;
MDH, malate dehydrogenase. Lipids extracted from 400 μl each of fractions were
developed and detected by FLA-5000 Imaging Analyzer and iodine vapor. Phospholipids
were as in Fig. 2. (C) Amounts of PE (diamond) and lyso-PE (triangle) in each fraction (B)
were quantiﬁed and represented as recovery from the total loaded.
Fig. 5. Transport of PlsEtn to post-Golgi compartments. (A) Effect of cholesterol-
affecting drugs on the distribution of plasmalogens. CHO-K1 cells were treated with
10 mM β-MCD or 0.4% saponin as described in Materials and methods. Cells were
solubilized with ice-cold 1% Triton X-100 and subjected to ﬂotation into OptiPrep step-
gradients. Two fractions each containing the detergent-resistant (R) and detergent-
soluble (S) materials were collected and analyzed for distribution of lipids. Twice
volumes of respective R fractions were used for phospholipids analysis. Phospholipids
were detected with iodine vapor. Lanes: 1 and 4, control; 2 and 5, β-MCD; 3 and 6,
saponin. (B) CHO-K1 cells were pre-treated for 1.5 h with 5 μg/ml of BFA, 75 μM NDGA,
or 10 μM nocodazole (Noco) or for 1 h with 10 mM NaN3/NaF (-ATP) and were then
labeled with 14C-ethanolamine for 4.5 h in the presence of these agents. R and S
fractions were prepared as in (A) and analyzed for distribution of proteins including TfR
and ﬂotillin-2 (Flo2) and lipids. Phosphatidylcholine (PC) and SM were detected with
iodine vapor. Lyso-PE was detected by FLA-5000 Imaging Analyzer. (C) The amount of
PlsEtn in respective R fractionwas represented as the ratio of lyso-PE in the R fraction to
that in R+S fractions by taking as 1 in mock-treated cells.
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same as that of the untreated cells (data not shown), as reported
[41]. In the DRM (R) fraction, SM was lowered and that in the
detergent-sensitive (S) fraction was increased, notably in saponin-
treated cells (Fig. 5A). PlsEtn detected as lyso-PE in the R fraction was
signiﬁcantly reduced and that in the S fraction was apparently
increased (Fig. 5A), hence indicating that the enrichment of PlsEtn in
DRMs was abrogated by depletion of the cellular cholesterol.
Accordingly, the PlsEtn transport to late compartments on the
exocytic route may be assessed by monitoring the partition of PlsEtn
into DRMs.Next, we investigated whether PlsEtn is transported to the
post-Golgi compartments via a classical secretory pathway. Several
secretory-pathway inhibitors, including brefeldin A (BFA), nordihy-
droguaiaretic acid (NDGA), and nocodazole [42-45], strongly
inhibited the transport to the cell surface of a newly synthesized
glycosylphosphatidylinositol-anchored protein tagged with yellow
ﬂuorescent protein (data not shown). No distinct difference was
discernible between the inhibitor-treated and untreated CHO-K1
cells in the partition of ﬂotillin-2 and SM (Fig. 5B, lanes 3–8),
suggesting that the integrity of rafts was not abrogated by the
treatment. We also determined the PlsEtn level in DRMs from
CHO-K1 cells treated with inhibitors. After cell-treatment with BFA
and nocodazole, PlsEtn was detected in DRMs only at ∼10%
reduced level as compared to that from untreated cells (Fig. 5C),
thereby implying that PlsEtn was mainly, if not all, transported to
the post-Golgi compartments via a non-secretory pathway in a
manner independent of microtubules. In contrast, by cell-treatment
Fig. 6. Analysis of proteins and lipids in DRMs from plasmalogen-deﬁcient cells. DRMs
were prepared from CHO-K1, ZPEG251, and peroxisome-deﬁcient pex2 Z65 and pex12
ZP109 cells labeled with 14C-acetate. R and S fractions were separated as in Fig. 5.
Distribution of cholesterol (A, upper panel), phospholipids (A, lower panel), and
proteins (B) was determined. Equal volumes of respective R and S fractions were used
except for phospholipids analysis (A) in which twice volumes of R fractions from
respective types of cells were used as in Fig. 5. Phospholipids were as in Fig. 2. (C)
Distribution to DRMs of SM (open bar), PC (dark-gray bar), PS/PI (gray bar), PE (light-
gray bar), and cholesterol (solid bar) was shown. The amount of each lipid in R fraction
was represented as percentages of the total in R+S fractions.
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despite that PlsEtn synthesis was at 10% of control CHO-K1
(Fig. 5B, lanes 5 and 6). NDGA reduces the cellular ATP level [44],
inferring that the decreased PlsEtn may be caused by the low ATP
upon NDGA-treatment. The cellular ATP was indeed reduced to
∼27% and ∼10% levels of that in the untreated cells, after 1.5-h
treatment with NDGA and following 4.5-h labeling with 14C-
ethanolamine, respectively (data not shown). When cells were
treated with NaN3 and NaF to reduce the cellular ATP to 10% of
the control (Fig. 5B, lanes 9 and 10), PlsEtn in DRMs was decreased
to ∼60% of that in the control cells (Fig. 5C). Therefore, it is likely
that PlsEtn is transported to the post-Golgi compartments in a
manner partially dependent on ATP.
3.5. Lipid rafts in plasmalogen-deﬁcient cells
In PM of many species of eukaryotes, aminophospholipids such as
phosphatidylethanolamine and phosphatidylserine reside in the inner
leaﬂet. The localization of PlsEtn in the inner leaﬂet of PM was shown
in sarcolemma and red blood cells [46,47]. Together with our present
ﬁnding that PlsEtn is enriched in DRMs, such reports prompted us to
investigatewhether or not the deﬁciency of PlsEtn affects the integrity
of lipid rafts, especially the inner leaﬂet rafts in PM. DRMs were
isolated from CHO-K1 and plasmalogen-deﬁcient CHO cell mutants
including ADAPS-defective ZPEG251 and peroxisome-biogenesis
impaired pex2 Z65 [4] and pex12 ZP109 [21]. Basically no difference
was observed between the mutants and CHO-K1 in the partitioning to
DRMs of lipids and several raft markers such as ﬂotillin-2, doubly
acylated Src-like kinase Fyn [48], and caveolin [37] (Figs. 6A and B).
We also compared the ratio of phospholipids and cholesterol between
DRMs and Triton X-100-extractable fraction from the cells that had
been metabolically labeled with 14C-acetate. Lipid composition and
quantiﬁcation in DRMs showed no apparent difference between CHO-
K1 andmutants in the recovery of cholesterol and phospholipids (Figs.
6A and C).
To avoid any possible generation of non-physiological clusters
of raft lipids and proteins by extraction with detergent [27,49], we
isolated by a detergent-free method a membrane fraction free
from non-raft PM and intracellular membranes from CHO-K1 and
ZPEG251 cells. In the subcellular fractionation of CHO-K1 cells,
non-raft marker proteins, TfR and P450R, were excluded from
fraction 5 with the lowest density that contained raft marker
proteins, ﬂotillin-2, Fyn, H-Ras [50,51], caveolin, and Gαq subunit
of heterotrimeric G-proteins [52] (Fig. 7, left panel). These proteins
were likewise recovered in the fraction 5 from ZPEG251, thereby
suggesting that plasmalogens were less likely structural lipids in
the lipid rafts.Table 1
Lipid contents of DRMs isolated from CHO-K1 cells
SM PC PS/PI PE PlsEtn
Recovery in DRMs (%)a 84 17 5.3 21 30
Radioactivity in total cell (%)b 8.5 55 12 10 11
Radioactivity in DRMs (%)c 7.1 9.6 0.64 2.1 3.4
Fold-enrichmentd 4.8 1.0 0.3 1.2 1.7
a DRMs were isolated from CHO-K1 cells labeled with 14C-acetate. Lipids were
extracted as described in Fig. 6, analyzed on TLC, and quantiﬁed by Fuji-Film FLA-5000
Phophorimager. PC, phosphatidylcholine; PI, phosphatidylinositol; PS, phosphatidyl-
serine. All values given as an average were from two independent experiments.
b Data from [12].
c Calculated from values in a and b.
d Lipids were grouped into SM and glycerophospholipids (PC+PS/PI+PE+PlsEtn). The
fold of enrichment of SM and respective glycerophospholipid including PlsEtn in DRMs
was calculated as follows. SM/glycerophospholipids and each glycerophospholipid/
glycerophospholipids in DRMs were divided by those of total cell.3.6. Alternative method for supplementation of PlsEtn
The sn-2 position of PlsEtn is mostly occupied by long-chain
polyunsaturated fatty acids of the n-6 or n-3 class [36,53,54]. In
patients lacking plasmalogens such as those with Zellweger
syndrome, docosahexaenoic acid level is also lowered in all of
tissues examined [36,55,56]. The plasmalogen deﬁciency in such
affected cells can be restored by supplementation of HG [3].
However, it is impossible to modulate the fatty acids at sn-2 position
of PlsEtn. We here veriﬁed if plasmalogen-deﬁcient ZPEG251 is
restored by supplementing puriﬁed plasmalogens. ZPEG251 cells
were cultured for 48 h in the presence of plasmalogens that had been
puriﬁed from bovine brain or chemically synthesized. Lyso-PE was
detected nearly at the same level as in HG-supplemented ZPEG251
and CHO-K1, hence indicating that the plasmalogens were efﬁciently
incorporated into the cells (Fig. 8A). Furthermore, subcellular
distribution of PlsEtn was very similar to that in CHO-K1 cells
Fig. 8. Incorporation of plasmalogens in ZPEG251. (A) ZPEG251 cells were cultured for
48 h in the presence of HG, bovine brain-derived PlsEtn (PlsEtn (b)), or chemically
synthesized plasmalogens (PlsEtn (c)) and were analyzed for phospholipids as in Fig. 2.
CHO-K1 was used as a control. (B) Subcellular distribution of PlsEtn (b) supplemented
into ZPEG251. Subcellular fractionation was done as in Fig. 4B. Each fraction was
assessed for phospholipids and marker proteins, Na+/K+-ATPase, P450R, and Rab11,
which were speciﬁc for PM, ER, and recycling endosomes, respectively.
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up from the outside of cells.
4. Discussion
In the present work, we isolated by the P9OH/UV selection method
a plasmalogen-deﬁcient CHO cell mutant ZPEG251 yet showing
morphologically normal peroxisomes from parent TKa cells expres-
sing PTS2-EGFP. ZPEG251 is impaired in the biogenesis of ADAPS,
owing to the defective expression of ADAPS mRNA. Accordingly,
ZPEG251 apparently belongs to the same complementation group as a
CHO cell mutant NZel-1 isolated by a combination of the P9OH/UV
method and autoradiographic screening [1] and ﬁbroblasts from
patients with a peroxisomal disorder, rhizomelic chondrodysplasia
punctata type 3 [57,58]. Nagan et al. [12] also isolated a DHAPAT-
defective CHO mutant NRel-4 by a two-step selection method using
sequential P9OH/UV and 12-(1′-pyrene)dodecanoic acid (P12)/UV
treatments. Our single selection-step protocol using the P9OH/UV
treatment did not include the second step, re-seeding of P9OH/UV-
resistant cells for the selection by the P12/UV treatment that killed
peroxisome-deﬁcient mutants. We used as a modiﬁed second step
EGFP morphology, where the functional import of PTS2-EGFP to
peroxisomes was monitored by EGFP ﬂuorescence in P9OH/UV-
resistant mutants, thereby accelerating the mutant screening. Thus,
cell mutants deﬁcient in plasmalogens can be more readily isolated by
this method.
In regard to the distribution of plasmalogens, only several reports
described the presence in synaptic vesicles [9,10] and secretory
granules [11]. Analysis of phospholipids species in rat liver peroxi-
somes by electrospray ionization mass spectrometry showed that PE
constitutes 38% of total phospholipids of peroxisomes, compatible
with our earlier ﬁndings [34], with no detectable amount of ether
lipids [35]. Non-peroxisomal accumulation of ether lipids was likewise
reported in COS cells by visualizing ether lipids with polyene
ﬂuorescence [59]. In our subcellular fractionation of CHO-K1 cells,
PlsEtn was mainly detected in the ER and post-Golgi compartment
fractions (Fig. 4). The enrichment of PlsEtn in DRMs conﬁrmed the
localization of PlsEtn in the post-Golgi compartments. From these
results, it is plausible that a speciﬁc mechanism underlies the
transport of PlsEtn from its synthesis site, ER, to the post-Golgi
compartments.
Following the third step in plasmalogen biosynthesis, PlsEtn and a
part of PE share the common step that is catalyzed by acyl/alkyl-DHAPFig. 7. Lipid rafts in plasmalogen-deﬁcient cells. PNS fractions from CHO-K1 and
ZPEG251 cells were ﬂoated up into OptiPrep step-gradients. Equal volumes of respective
fractions were analyzed by immunoblot for distribution of non-raft maker proteins, TfR
and P450R, and proteins associated with rafts on cytoplasmic surface. Lipid analysis was
done as in Fig. 5.reductase [60,61] through the CDP-ethanolamine pathway. Transport
of de novo synthesized PE from its site on the ER to PM was not
affected by cell-treatment with BFA [62]. In mitotic cells, PE was
transported to the PM, where a number of cellular processes involving
intracellular transport were inhibited [63]. In these reports, PE
molecules reaching the external leaﬂet of PM were monitored using
trinitrobenzene sulfonate which reacted with the amino group of
ethanolamine on the outside surface of the cell [64]. However, PE and
PlsEtn are indistinguishably labeled per se with trinitrobenzene
sulfonate. Therefore, in the present work, we focused on the PlsEtn
transport to the post-Golgi compartments bymonitoring the partition
of PlsEtn to DRMs. Based on our ﬁndings, PlsEtn is likely transported to
the post-Golgi compartments mainly via non-secretory pathway
bypassing the Golgi complex, in amanner independent of microtubule
and dependent on the cellular ATP level. Contrary to our ﬁndings, the
appearance of newly synthesized PE at the PM was not abrogated by
the energy poison in V79 Chinese hamster ﬁbroblast [64]. Such
apparent difference between PE and PlsEtn in the ATP requirement for
the transport to the PM remains to be deﬁned. Similar to the PlsEtn
transport, delivery of cholesterol to cell surface was shown to be ATP-
dependent [65]. However, the transport of newly synthesized
cholesterol from ER to the PM is normal in plasmalogen-deﬁcient
cells [5], implying that PlsEtn is not required for the cholesterol
transport to PM. Whether the delivery of PlsEtn to the PM takes place
via direct contact between the membranes or with the aid of cytosolic
transfer proteins is unknown at present. It is of interest to note that
several proteins with the steroidgenic acute regulatory protein (StAR)-
related lipid transfer (START) domain may function as a lipid
transporter [66].
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PM were differentially enriched in DRMs. However, in plasmalogen-
deﬁcient ZPEG251 cells, no striking difference was noted in the
partitioning of cholesterol, SM, and several raft markers such as Src
and Gαq both anchoring to the inner leaﬂet of the lipid bilayer. These
results are not compatible with the report describing the reduced
level of association of ﬂotillin-1 and F3/contactin to microdomain in
the brain of DHAPAT-knockout mice [8]. The discrepancy between
these two ﬁndingsmay be explained by the fact that PlsEtn constitutes
∼20% mass of the total phospholipids in human brain white matter,
higher than in CHO-K1 cells [12]. Alternatively, PlsEtnmay be required
for the association of a set of proteins to the microdomains that are
fractionated into DRMs. Very recently, Surviladze et al. [67] reported
unique lipid compositions of the domains each harboring FcɛRI, the
high-afﬁnity receptor for immunoglobulin E, and glycosylphosphati-
dylinositol-anchored Thy-1. Despite the notion that FcɛRI and Thy-1
are recovered in DRMs upon their aggregation induced by immuno-
globulin E and anti-Thy1 antibody, respectively [68], Surviladze et al.
isolated speciﬁc domains containing each protein from RBL-2H3 cells
by the detergent-free immunoisolation method. PlsEtn was enriched
in the FcɛRI domain as compared to the Thy-1 domain. Studies with
tissues and cells from the plasmalogen-defective mouse models such
as DHAPAT-knockout mice [8] are also informative on the functions of
plasmalogens, particularly in speciﬁc tissues.
The deﬁciency of plasmalogens in ZPEG251 was restored in culture
by supplementation of plasmalogens as well as chemically synthe-
sized 1-O-1′-(Z)-octadecenyl-2-oleoyl-sn-glycero-3-phosphoethano-
lamine. The sn-1 position of PlsEtn is linked almost exclusively to
C16:0, C18:0, and C18:1 fatty alcohols, while ether phospholipids
usually contain long-chain polyunsaturated fatty acids at the sn-2
position, hence postulating that PlsEtn may function as a storage of
polyunsaturated fatty acids and lipid mediators [53]. Our successful
supplementation to cells of plasmalogens and HG would also open a
way to addressing the physiological role of the sn-2 position of PlsEtn.
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